Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial

INTRODUCTION: Senticol 2 is a randomized multicenter trial in the treatment of early-stage cervical cancer patients. The aim of the Senticol 2 study was to compare the effect of sentinel-lymph-node biopsy (SLNB) to that of SLNB + pelvic lymphadenectomy (PLND), and to determine the postoperative lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Favre, Guillaume, Guani, Benedetta, Balaya, Vincent, Magaud, Laurent, Lecuru, Fabrice, Mathevet, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927597/
https://www.ncbi.nlm.nih.gov/pubmed/33680944
http://dx.doi.org/10.3389/fonc.2020.621518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927597/
https://www.ncbi.nlm.nih.gov/pubmed/33680944
http://dx.doi.org/10.3389/fonc.2020.621518

Ejemplares similares